Treatment of Parkinson's disease: Focus on quality of life issues

Parkinsonism and Related Disorders

Volumn 18, Issue SUPPL. 1, 2012, Pages

  Uitti, Ryan J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Parkinson's disease; Quality of life; Treatment

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CITALOPRAM; DESIPRAMINE; DONEPEZIL; NORTRIPTYLINE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; DOPAMINE RECEPTOR STIMULATING AGENT;

ANXIETY; ARTICLE; DEPRESSION; DISEASE COURSE; DRUG EFFICACY; EXERCISE; HIPPOCAMPUS; HUMAN; INDEPENDENCE; MILD COGNITIVE IMPAIRMENT; MOTOR DYSFUNCTION; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PARKINSON DISEASE; PATIENT EDUCATION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; QUALITY OF LIFE; RISK FACTOR; RISK REDUCTION; SEDENTARY LIFESTYLE; SLEEP DISORDER; SYMPTOM; WALKING; WORK CAPACITY; DEMENTIA; FALLING; INJURY; MENTAL HEALTH; MOOD DISORDER; PATIENT ADVOCACY; PATIENT ATTITUDE;

EID: 84858649390     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/s1353-8020(11)70013-x     Document Type: Article

References (20)

1. Winter Y, von Campenhausen S, Arend M, Longo K, Boetzel K, Eggert K, et al. Parkinsonism Relat Disord 2011;17:265-9.
2. Barone P. Treatment of depressive symptoms in Parkinson's disease. Eur J Neurol 2011;18:11-5.
3. Schuurman AG, van den Akker M, Ensinck KT, Metsemaker JF, Knottnerus JA, Leentjens AF, et al. Increased risk of Parkinson's disease after depression. Neurology 2002;58:1501-4.
4. Braak H, Braak E. Pathoanatomy of Parkinson's disease. J Neurol 2000; 247(Suppl 2):II3-10.
5. Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psychiatry 2000;69:308-12.
6. Shulman LM, Taback RL, Rabinstein AA, Weiner WJ. Non-recognition of depression and other non-motor symptoms in Parkinson's disease. Parkinsonism Relat Disord 2002;8:193-7.
7. Weintraub D, Moberg PJ, Duda JE, Katz IR, Stern MB. Recognition and treatment of depression in Parkinson's disease. J Geriatr Psychiatry Neurol 2003;16:178-83.
8. Menza M, Dobkin RD, Marin H, Mark MH, Gara M, Buyske S, et al. The impact of treatment of depression on quality of life, disability and relapse in patients with Parkinson's disease. Mov Disord 2009;24:1325-32.
9. Price A, Rayner L, Okon-Rochal E, Evans A, Koravangattu V, Higginson IJ, et al. Antidepressants for the treatment of depression in neurological disorders: a systematic review and meta-analysis of randomised controlled trials. J Neurol Neurosurg Psychiatry 2011;82:914-23.
10. Devos D, Dujardin K, Poirot I, Moreau C, Cottencin O, Thomas P, et al. Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study. Mov Disord 2008;23:850-7.
11. Menza M, Dobkin RD, Marin H, Mark MH, Gara M, Buyske S, et al. A controlled trial of antidepressants in patients with Parkinson disease and depression. Neurology 2009;72:886-92.
12. Uitti RJ, Ahlskog JE, Maraganore DM, Muenter MD, Atkinson EJ, Cha RH, et al. Levodopa therapy and survival in idiopathic Parkinson's disease - Olmsted county project. Neurology 1993;43:1918-26.
13. Jasinska-Myga B, Heckman MG, Wider C, Putzke JD, Wszolek ZK, Uitti RJ. Loss of ability to work and ability to live independently in Parkinson's disease. Parkinsonism Relat Disord 2011 Oct 3 [Epub ahead of print]. doi: 10.1016/ j.parkreldis.2011.08.022.
14. Thacker EL, Chen H, Patel AV. Recreational physical activity and risk of Parkinson's disease. Mov Disord 2008;23:69-74.
15. Xu Q, Park Y, Huang X, Hollenbeck A, Blair A, Schatzkin A, et al. Physical activities and future risk of Parkinson disease. Neurology 2010;75:341-8.
16. Ahlskog JE. Does vigorous exercise have a neuroprotective effect in Parkinson disease? Neurology 2011;77:288-94.
17. Lautenschlager NT, Cox KL, Flicker I, Foster JK, van Bockxmeer FM, Xiao J, et al. Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. JAMA 2008;300:1027-37.
18. Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Farris S, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 2005;352:2379-88.
19. Erickson KI, Prakash RS, Voss MW, Chaddock L, Hu L, Morris KS, et al. Aerobic fitness is associated with hippocampal volume in elderly humans. Hippocampus 2009;19:1030-9.
20. Erickson KI, Voss MW, Prakash RS, Basak C, Szabo A, Chaddock L, et al. Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci USA 2011;108:3017-22.